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ABSTRACT: Objective—The aim of the present randomized study was to investigate w hether ovarian s tim u­
lation treatm ent with gonadotropin preparations containing different am ounts of LH activity resulted in 
variations of steroidal composition of follicular fluid. A different endocrine m ilieu w ith in  the follicle m ight 
influence oocyte quality. Methods—Antral fluid from m ature follicles was collected in in vitro fertilization 
cycles and concentrations of testosterone, androstenedione, estrone, estradiol, progesterone, FSH, and LH 
were determ ined. A com parison was m ade betw een trea tm en t w ith  a purified  FSH prepara tion  (nine 
patients, 35 follicular fluid samples) and a FSH-dominant hum an menopausal gonadotropin (hMG) prepara­
tion (nine patients, 34 samples). Results—No differences in any of the horm one levels could be detected 
between the two groups. Conclusion—Treatm ent w ith  gonadotropin preparations contain ing  different 
FSH/LH ratios did not result in different androgen, estrogen and progesterone levels in follicular fluid. I n t  J
Fertil 42(6):426-430, 1997
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INTRODUCTION
HE GENERALLY ACCEPTED THEORY 
for the m echanism  of estradiol production 
by th e  ovary is the  tw o-cell tw o-gonado­
tro p in  concep t [1]. T h is m eans th a t LH 
stim ulates androgen synthesis in cells of the theca 
in te rn a  a ro u n d  th e  ovarian  fo llic le  [2]. T h eca l 
androgens are transported  to  the  granulosa cells, 
where they are arom atized into estrogens [3]. FSH 
stim ulates the necessary aromatase activity in the 
granulosa cells [4,5]. T he estrogens are secreted  
into the follicular fluid and the blood circulation. 
As the follicle m atures, the estradiol concentration 
in follicular fluid increases significantly.
If ovarian hyperstim ulation treatm ent is applied, 
for instance in  in vitro fertilization (IVF) cycles, dif­
ferent s tim u la tio n  protocols can be used. In gen­
e ra l, th e  a d m in is t r a t io n  of a g o n a d o tro p in  
p rep a ra tio n  is p receded  by and com bined  w ith  
adm in istra tion  of a GnRH agonist (GnRHa). Sev­
eral gonadotropin preparations containing FSH and 
LH activity in  various am ounts can be applied for 
ovarian stim ulation. In the present study, we inves­
tig a te d  w h e th e r  t r e a tm e n t  w ith  g o n ad o tro p ic  
preparations contain ing  different am ounts of LH 
activity resulted in  a different steroid composition 
in  th e  an tra l flu id  of m atu re  follicles. Thus, we 
tested w hether lower am ounts of exogenous LH led 
to a decrease in androgen production by the thecal 
cells, to low er estradiol production by the granu­
losa cells, and to low er fo llicu lar flu id  estradiol 
concentrations. Differences in the endocrine m ilieu 
of the oocyte m ight influence oocyte quality. In a 
random ized study in  IVF patients, treatm ent w ith  
p u r if ie d  u r in a r y  FSH w as co m p ared  w ith  a 
gonadotropic preparation comprising FSH and LH 
activity in  a ratio of 3:1. Concentrations of andro­
gens, estrogens, progesterone, FSH, and LH in fol­
licular fluid were compared.
METHODS 
Patients
Twenty w om en undergoing IVF treatm ent for tubal 
pathology or unexplained infertility participated in 
the study. The inclusion criteria were: age between 
20 and 40 years, norm al endocrine serum  profile in  
the early follicular phase of the cycle (FSH concen­
tra tio n  below  8 IU/L, LH/FSH ratio  less than  3, 
testosterone concentration below 2.5 nmol/L, pro­
lac tin  concen tra tion  below  700 m lU /L  and th y ­
roxin concentration between 58 and 148 nmol/L), 
no horm onal medication for at least two m enstrual 
cy c le s  p r io r  to  th e  s tu d y , no  e n d o m e tr io s is  
observed on laparoscopy, both ovaries present, and 
no m ale subfertility (at least 20 x 10^ sperm/mL, at 
least 50% m otile  sperm , m o tility  grade at least 
fairly good, at least 60% morphologically norm al 
sperm and absence of anti-sperm antibodies as con­
firmed by the direct immunobead test, or a fertil­
ization rate of at least 50% if the patient had had 
IVF before).
The study was approved by the hospital's Ethical 
C om m ittee and all the women gave their informed 
consent.
Treatment Protocol
T h e  w o m en  w ere  ran d o m ly  d iv ided  in to  tw o  
groups: one group of ten women was treated w ith  
purified urinary FSH (ratio FSH/LH activity  >60, 
M etrodin, Serono, Pharm a-Im port BV, H aarlem , 
The Netherlands): Group A; the other group of ten  
women was treated w ith  a preparation containing 
FSH and LH activity in a ratio of 3:1 (Normegon, 
NV O rganon, Oss, T he N etherlands): G roup B. 
Each preparation was administered intram uscularly 
(i.m.) in a fixed daily dose of 150 IU. Details about 
IVF resu lts and serum  horm one levels were pub­
lished previously [6].
G on ad o tro p in  a d m in is tra tio n  w as com bined  
w ith  buserelin (Suprefact, Hoechst AG, Frankfurt, 
Germany) treatm ent, w hich started  on day 21 of 
th e  m e n s tru a l cycle, in  a daily  dose of 900 jug 
intranasally. On the ten th  day of buserelin trea t­
m ent, the serum estradiol concentration was deter­
m in e d  by  tim e -re so lv e d  f lu o ro im m u n o a s s a y  
(DELFIA, Wallac Oy, Turku, Finland). If the estra­
diol concentration was below 500 pmol/L, adm inis­
tration of gonadotropins was started the next day; 
if th e  serum  es trad io l c o n c e n tra tio n  w as s t i l l  
h igher th a n  500 pm ol/L , th e  a d m in is tra tio n  of 
gonadotropins was postponed u n til it was below 
500 pmol/L. Buserelin adm inistration was contin­
ued un til the day of hum an chorionic gonadotropin 
(hCG) administration.
T ransvaginal u ltrasonography  w as perform ed 
every other day during the stim ulation phase of the 
IVF cycle to m easure  fo llicu la r grow th. Serum
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estradiol concentrations were determ ined by the 
time-resolved fluoroimmunoassay procedure. The 
adm inistration of gonadotropins was discontinued 
as soon as at least three follicles were present with 
a (largest) diam eter >15 mm, one of w hich had a 
diameter >20 mm, and the serum estradiol concen­
tration was approximately 1,000 pmol/L per large 
follicle (>15 mm). In one patient of each group the 
IVF trea tm en t had to be canceled before oocyte 
retrieval because of a significant drop in the estra­
diol level.
Transvaginal ultrasound-guided oocyte retrieval 
was performed 35 hours after the hCG injection. 
Follicular fluid from the four largest follicles was 
collected separately. In three patients, fluid from 
only three follicles could be collected. The follicu­
lar fluid was not diluted w ith flushing medium or 
flu id  from  ano ther follicle. The flu id  was cen­
trifuged for 10  m inutes at 2,000  xg and stored at 
-20°C u n til assayed. Embryo transfer was per- 
formed on the third day after oocyte retrieval. The 
lu teal phase of the  cycle was supported by i.m. 
hCG injections.
Assays
Concentrations of estradiol and progesterone in fol­
licular fluid were determined by radioim m unoas­
says (RIA), as described  by T hom as e t al [7]. 
Concentrations of estrone [8], testosterone [9], and 
androstenedione [10] w ere determ ined  by RIAs 
developed in th is laboratory. C oncentrations of 
FSH and LH were measured by immunoradiometric 
assay (IRMA) procedures [11].
Statistics
b
Results are expressed as median values w ith  tenth 
and ninetieth percentiles. Statistical analysis was 
perform ed using the tw o-sam ple W ilcoxon te s t 
(rank sum  test). C orrelations w ere detected  by 
Spearman's rank correlation test. Differences w ith 
P < .01 were considered significant. The two can­
celed cycles were not included in the evaluation.
RESULTS
Table I lists the cycle characteristics of th e  two 
groups. Serum LH concentrations were higher in
TABLE 1
Cycle characteristics of the study groups.
Group A Group B
Treatment Metrodin Normegon
No. of patients 9
*
9
*
No. of treatment days 9 (9, 15) 8 (7, 10)
No. follicles >15 mm^ 6 (5, 11) 9 (4, 19)
Serum estradiol 5,700 7,500
(pmol/L)1- (2,200, 9,800| (4,240, 13,400)
Serum LH (IU/Lp 1.6 (1.1, 2.9)* 3.2 (1.7, 4.0)
No, oocytes 8 (6, 1 1 ) 13 (5,21)
Fertilization rate ( % ) 67 (22, 100) 63 (14, 100)
Median values, tenth, and ninetieth percentiles in paren­
theses.
*.01 <P< .05
^On the day of hCG administration.
G roup B th a n  in  G roup A on th e  day of hC G  
adm inistration (.01 < P < .05), w hich m ight be an 
effect of adm inistration of exogenous LH in Group 
B. This observation is rather unexpected, since the 
half-life of LH is very short [12]. T he to tal num ber 
of follicular fluid samples was 35 in  Group A and 
34 in Group B. Median values of the horm one con­
centrations in the three or four follicular fluid sam ­
ples collected were calculated for each patient. The 
m edian value of these individual .median concen-
TABLE II
Median values of individual median 
concentrations of hormones in follicular fluid 
after ovarian stimulation treatment with 
Metrodin (9 women) or Normegon (9 women).
Metrodin Normegon
Number of samples 35 34
Testosterone (nmol/L) 13.5 (8.0, 19.5) 13.0 (8.2, 15.0)
Androstenedione
(nmol/L) 57 (23, 144) 42 (26, 153)
Estradiol (¡nmol/L) 2.6 (1.4, 3.8) 2.6 (1.5, 3.7)
Estrone (nmol/L) 150 (104, 204) 160(120, 263)
Progesterone (pnol/L) 33 ¡23, 52) 32(19, 53)
LH (IU/L) <1.0 <1.0
FSH (IU/L) 1.6 (1.3, 2 .2 ) 1.7 (1.0, 2.7)
Tenth and ninetieth percentiles are given in parentheses.
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trations was determ ined in each group. The results 
are listed in Table IL There were no significant dif­
ferences betw een the two groups for any of the ho r­
mones determ ined.
Follicular fluid steroid levels were considerably 
higher than serum  steroid levels. Androstenedione 
and te s to s te ro n e  concen tra tions w ere about ten  
tim es h igher th an  th e  norm al serum  concen tra­
tions. Estrone, estradiol, and progesterone concen­
tra tio n s  w ere abou t one th o u san d  tim es h igher 
than serum  levels. The elevated progesterone levels 
indicated th a t the process of luteinization follow­
ing hCG adm inistration  had already started. Con­
centrations of FSH were lower than in  serum, and 
LH concen tra tions in  follicular fluid w ere unde- 
tectably low.
No significant correlations were found between 
the individual fertilization rates (percentage fertil­
ized oocytes) and m edian concentrations of testos­
te ro n e , a n d ro s te n e d io n e , e s tro n e , e s tra d io l, 
androgens (te s to s te ro n e  p lus androstened ione), 
estrogens (estrone plus estradiol), th e  androgen/ 
estrogen ratio, and the progesterone/estradiol ratio. 
A positive correlation existed between the fertiliza­
tion rate and progesterone concentrations in Group 
B [P < .01), b u t not in  Group A.
DISCUSSION
T he tw o gonado trop ic  p repara tions used  in  th e  
p resen t s tu d y  co n ta in  d ifferen t am oun ts  of LH 
activity . R educing th e  am oun t of exogenous LH 
m ay re su lt in  less LH s tim u la tio n  of the  ovary. 
This m ight affect the rate of androgen production 
by the theca cells and subsequent estrogen produc­
tio n  in  th e  g ran u lo sa  ce lls . Low er am o u n ts  of 
exogenous LH may, therefore, result in a decrease 
of androgen and estrogen levels in follicular fluid.
In both study groups, high androgen and estrogen 
levels were present in the follicular fluid. Comparing 
treatm ent w ith  purified FSH (Group A) and a FSH- 
dominant hM G preparation (Group B), no differences 
were seen in the m edian concentrations of steroids 
and of FSH and LH. N o evidence for a decrease in fol­
licular fluid estradiol concentrations after treatm ent 
w ith the preparation w ith  the lowest LH content was 
found. T hus, the  endocrine m ilieu  of the  oocyte 
appeared to be similar in the two groups.
However, a comparison betw een the two groups 
can only be m ade w ith  certain reservations. One of
the criteria  for hCG  adm inistration was a serum  
estradiol concentration of 1,000 pmol/L per large 
follicle. If, as we already stated, the estradiol p ro­
duction  was indeed lower in  the group w ith  th e  
low er exogenous LH ad m in is tra tio n  (Group A), 
serum  estradiol levels would also be lower. Since 
the serum  estradiol level was required to reach a 
certain  m in im um  before hCG was adm inistered, 
th is  w ould  m ean th a t oocyte retrieval w ould be 
postponed, and the follicles would be more m ature 
at the tim e of ovum pickup. Indeed, the num ber of 
tre a tm e n t days was h igher in  G roup A. th a n  in  
Group B. Since m aturation  of the follicle has an 
im pact on the steroidal composition of the follicu­
lar fluid [13], this could mean that the two groups 
were not completely comparable.
Several studies on the steroidal com position of 
follicular fluid in  IVF cycles have been reported  
[14-17]. Generally, in comparison w ith  our results, 
sim ilar values of estradiol, androstenedione, testos­
terone, and progesterone were found. Only m inor 
differences between the results of the studies were 
observed, bu t these may be caused by th e  use of 
different RIAs and by variations in the stim ulation 
protocol. Suchanek et al [16] reported m ean FSH 
levels in  fo llicu la r flu id  (10.6 IU/L) th a t  w ere  
higher th an  those in our study. The discrepancy 
may be explained by the assay used: they applied a 
RIA, while we used an IRMA.
In summary, in  the present study, follicular fluid 
steroid  concentrations were sim ilar after ovarian 
stim ulation w ith either a FSH-dominant or a puri­
fied FSH preparation.
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